secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2023-04-11T23:59:59+00:00
Accession:  0001493152-23-011838
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Abeona Therapeutics reduces board size to seven; Chairman moves director class for compliance
--------------------------------------------------------------------------------

- Board size decreased from nine to seven directors, effective at 2023 Annual Shareholder Meeting.
- Chairman Michael Amoroso relinquished Class 2 seat and was appointed Class 1 director to maintain equal class sizes.
- Amoroso's service is deemed continuous; no new compensatory arrangements were entered into.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315223011838/0001493152-23-011838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315223011838/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-011838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer